TWO SIGMA ADVISERS, LP

Holdings History for Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN)

Symbol: VRDN on Nasdaq
Investment type: Equity / Common Stock, $0.01 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0%	$0	0	-93,800	-100%	$28.29	Q3 2025
30 Jun 2025	0%	-0%	$1,311,324	93,800	-99,500	-51%	$13.98	Q2 2025
31 Mar 2025	0.01%	-0%	$2,605,684	193,300	-142,269		$13.48	Q1 2025
31 Dec 2024	0.01%	-0%	$6,432,858	335,569	-109,231	-25%	$19.17	Q4 2024
30 Sep 2024	0.02%	-0%	$10,119,200	444,800	-81,900	-16%	$22.75	Q3 2024
30 Jun 2024	0.02%	+0.01%	$6,852,367	526,700	+222,300	+73%	$13.01	Q2 2024
31 Mar 2024	0.01%	+0.01%	$5,330,044	304,400	+204,100	+203%	$17.51	Q1 2024
31 Dec 2023	0.01%	+0%	$2,184,534	100,300	+80,000	+394%	$21.78	Q4 2023
30 Sep 2023	0%	+0%	$311,402	20,300	+10,800	+114%	$15.34	Q3 2023
30 Jun 2023	0%	+0%	$226,005	9,500	+9,500	NEW	$23.79	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.